Sign up to save your podcasts
Or
Share Helping Biosimilars Emerge into Global Markets Takes a Practiced Hand
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Helping Biosimilars Emerge into Global Markets Takes a Practiced Hand
Currently, almost 60 percent of drugs in development are being created by emerging biotech companies focused on therapies for niche diseases with small patient populations. For emerging biotech and small companies in early-stage clinical development, accessing the market as quickly as possible is immensely important. In 2013, Turgut Pharmaceuticals, headquartered in Istanbul, recognized the growing […]
View all episodes
By M Lab Podcasts from MilliporeSigma and GENCurrently, almost 60 percent of drugs in development are being created by emerging biotech companies focused on therapies for niche diseases with small patient populations. For emerging biotech and small companies in early-stage clinical development, accessing the market as quickly as possible is immensely important. In 2013, Turgut Pharmaceuticals, headquartered in Istanbul, recognized the growing […]